# SUMATRIPTAN SUCCINATE
> **ANDA213518** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2025-11-06
## Drug
- **FDA Application Number:** ANDA213518
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** SUMATRIPTAN SUCCINATE
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2025-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213518)
---
*MORVS · CC0 1.0*